Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Grunenthal

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Grunenthal's 2013 immunology sales performance.

Deal Watch June 2016

Deal Watch June 2016 As part of the transaction Grünenthal has the option to take over manufacturing of Zurampic from AstraZeneca from October 2021. ... licence. 270. AstraZeneca/ Grünenthal. Zurampic (lesinurad) and lesinurad fixed-dose combo with allopurinol for

AZ’s Gabriel Baertschi joins Grünenthal as CEO

AZ’s Gabriel Baertschi joins Grünenthal as CEO He also becomes chairman of the corporate executive board. Aachen, Germany-headquartered Grünenthal has named AstraZeneca's Gabriel Baertschi as its new chief executive officer, with effect from 1 October. ... His deep experience in growing the business

Explosive evolution

Explosive evolution to dominate specialities, such as Grünenthal in analgesia or Leo in parts of dermatology.

Concentric Health Experience eyes European expansion

Concentric Health Experience eyes European expansion Carr is the former owner of Courtney Alexander Consulting Limited, where his client roster included Actelion, Grunenthal, Pfizer, Roche Products and various NHS Trusts.

Golden night for Saatchi & Saatchi at the PM Society Awards

Golden night for Saatchi & Saatchi at the PM Society Awards Target Award for House Promotion - Havas Lynx. Target Award for Corporate Communications - MJL for Grunenthal.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups
A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...

Infographics